tiprankstipranks
Jaguar Animal Health (JAGX)
NASDAQ:JAGX

Jaguar Animal Health (JAGX) Stock Price & Analysis

2,065 Followers

JAGX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.05 - $1.22
Previous Close$0.07
Volume30.56M
Average Volume (3M)37.40M
Market Cap
$15.07M
Enterprise Value$38.30M
Total Cash (Recent Filing)$8.63M
Total Debt (Recent Filing)$31.66M
Price to Earnings (P/E)>-0.1
Beta1.03
Apr 01, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-6.88
Shares Outstanding50,755,589
10 Day Avg. Volume56,445,342
30 Day Avg. Volume37,403,741
Standard Deviation0.48
R-Squared0.02
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)-0.19
Price to Sales (P/S)1.07
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.46
Enterprise Value/Gross Profit3.85
Enterprise Value/Ebitda-1.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

4.66%0.27%0.17%94.90%
0.17% Other Institutional Investors
94.90% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

JAGX FAQ

What was Jaguar Animal Health’s price range in the past 12 months?
Jaguar Animal Health lowest stock price was $0.05 and its highest was $1.22 in the past 12 months.
    What is Jaguar Animal Health’s market cap?
    Currently, no data Available
    When is Jaguar Animal Health’s upcoming earnings report date?
    Jaguar Animal Health’s upcoming earnings report date is Apr 01, 2024 which is in 4 days.
      How were Jaguar Animal Health’s earnings last quarter?
      Jaguar Animal Health released its earnings results on Nov 14, 2023. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$1.23 by $0.85.
        Is Jaguar Animal Health overvalued?
        According to Wall Street analysts Jaguar Animal Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Jaguar Animal Health pay dividends?
          Jaguar Animal Health does not currently pay dividends.
          What is Jaguar Animal Health’s EPS estimate?
          Jaguar Animal Health’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Jaguar Animal Health have?
          Jaguar Animal Health has 206,757,250 shares outstanding.
            What happened to Jaguar Animal Health’s price movement after its last earnings report?
            Jaguar Animal Health reported an EPS of -$0.38 in its last earnings report, beating expectations of -$1.23. Following the earnings report the stock price went up 6.452%.
              Which hedge fund is a major shareholder of Jaguar Animal Health?
              Currently, no hedge funds are holding shares in JAGX
              ---

              Company Description

              Jaguar Animal Health

              Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Aytu BioScience
              Ocular Therapeutix
              Kala Pharmaceuticals
              Bio-Path Holdings
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis